Mild Progressive Multifocal Leukoencephalopathy After Switching From Natalizumab to Ocrelizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mild Progressive Multifocal Leukoencephalopathy After Switching From Natalizumab to Ocrelizumab
Neurol Neuroimmunol Neuroinflamm 2021 Jan 01;8(1)e904, AA Toorop, ZYG van Lierop, EEM Strijbis, CE Teunissen, A Petzold, MP Wattjes, F Barkhof, BA de Jong, ZLE van Kempen, J KillesteinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.